Icon (ICLR) Operating Margin (2009 - 2026)
Icon's (ICLR) quarterly Operating Margin came in at 6.68% in Q2 2026, down 465.0% year-over-year from 1.83% in Q2 2025, and down 21.8% quarter-over-quarter from 8.54% in Q1 2026.
Powered by 
Analysis
Icon (ICLR) Operating Margin (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Operating Margin for 18 consecutive years, with 6.68% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Margin fell 465.0% year-over-year to 6.68% in Q2 2026; TTM through Jun 2026 was 7.34%, a 584.0% decrease from a year earlier, with the FY2025 full-year figure at 12.27%, down 188.0% from the prior year.
- Operating Margin was 6.68% for Q2 2026 at Icon, down from 8.54% in the prior quarter.
- Over five years, Operating Margin peaked at 16.02% in Q4 2024 and troughed at 4.24% in Q3 2025.
- A 5-year average of 10.76% and a median of 10.9% in 2023 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin soared 1227 bps in 2022 and plunged 982 bps in 2025, its largest moves.
- Over 5 years, Operating Margin stood at 10.37% in 2022, then rose by 15 bps to 11.93% in 2023, then jumped by 34 bps to 16.02% in 2024, then plunged by 39 bps to 9.84% in 2025, then slumped by 32 bps to 6.68% in 2026.
- The last three Operating Margin figures came in at 6.68% (Q2 2026), 8.54% (Q1 2026), and 9.84% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 11.58% |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 20.76% |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 6.68% |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 11.94% |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.18% |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -290.47% |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -2.69% |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -218,381.69% |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -15,327.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.68% |
| Mar 31, 2026 | 8.54% |
| Dec 31, 2025 | 9.84% |
| Sep 30, 2025 | 4.24% |
| Jun 30, 2025 | 11.33% |
| Mar 31, 2025 | 11.26% |
| Dec 31, 2024 | 16.02% |
| Sep 30, 2024 | 14.06% |
| Jun 30, 2024 | 10.84% |
| Mar 31, 2024 | 13.66% |
| Dec 31, 2023 | 11.93% |
| Sep 30, 2023 | 12.86% |
| Jun 30, 2023 | 10.37% |
| Mar 31, 2023 | 10.96% |
| Dec 31, 2022 | 10.37% |
| Sep 30, 2022 | 12.55% |
| Jun 30, 2022 | 9.19% |
| Mar 31, 2022 | 8.96% |
| Dec 31, 2021 | 7.67% |
| Sep 30, 2021 | 0.27% |